Pro‐Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction
BackgroundUnderlying inflammation has been increasingly recognized in heart failure with a preserved ejection fraction (HFpEF). In this study we tested the hypothesis that pro‐inflammatory biomarkers are elevated in patients with acutely decompensated HFpEF (AD‐HFpEF) compared with patients with sta...
Hauptverfasser: | Abraham Abernethy, Sadi Raza, Jie‐Lena Sun, Kevin J. Anstrom, Russell Tracy, Johannes Steiner, Peter VanBuren, Martin M. LeWinter |
---|---|
Format: | Artikel |
Sprache: | English |
Veröffentlicht: |
Wiley
2018-04-01
|
Schriftenreihe: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Schlagworte: | |
Online Zugang: | https://www.ahajournals.org/doi/10.1161/JAHA.117.007385 |
Ähnliche Einträge
Ähnliche Einträge
-
Do we need a definition of acute heart failure with preserved ejection fraction?
von: Agnieszka Kapłon-Cieślicka, et al.
Veröffentlicht: (2021-01-01) -
Heart failure with preserved ejection fraction (HFpEF): Implications for the anesthesiologists
von: Ajmer Singh, et al.
Veröffentlicht: (2018-01-01) -
Soluble ST2 in Heart Failure With Preserved Ejection Fraction
von: Omar F. AbouEzzeddine, et al.
Veröffentlicht: (2017-02-01) -
Cell Therapy for Heart Failure With Preserved Ejection Fraction∗
von: Barry A. Borlaug, MD, et al.
Veröffentlicht: (2016-01-01) -
Common Heart Failure With Preserved Ejection Fraction Animal Models Yield Disparate Myofibril Mechanics
von: Axel J. Fenwick, et al.
Veröffentlicht: (2024-01-01)